ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,527,802, issued on Jan. 20, was assigned to Antares Pharma Inc. (Ewing, N.J.).
"Administration of testosterone compositions" was invented by Paul K. Wotton (Newtown, Pa.), Hermanus L. Jooste (Wayne, Pa.), Kaushik J. Dave (Edison, N.J.) and Jonathan Jaffe (Annandale, N.J.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides compositions and methods for treating a subject in need of treatment with testosterone, including introducing testosterone into the subject subcutaneously, intradermally, or intramuscularly, from a needle assisted jet injection device."
The patent was filed on Nov. 6, 2023, under Application No. 18/502,166.
...